![Flashlight Pro [Multipurpose LED light] icon](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/d7/bf/ae/d7bfaed5-3dfd-0bec-f088-983650770efa/pr_source.png/192x192bb.jpg)
KAVAPOINT
For healthcare professionals including physicians, nurses, and pharmacists, alongside general smartphone users seeking basic utility tools.
![Flashlight Pro [Multipurpose LED light] screenshot](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/76/bb/1a/76bb1a56-eba7-0d5f-a498-3eef36328ef8/pr_source.png/288x288bb.png)
![Flashlight Pro [Multipurpose LED light] screenshot](https://is1-ssl.mzstatic.com/image/thumb/Purple1/v4/6b/70/0b/6b700bbb-642a-07e7-23ba-e68167e2c77d/pr_source.png/288x288bb.png)
![Flashlight Pro [Multipurpose LED light] screenshot](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/e8/88/62/e8886237-b082-5696-ae05-35fe43c056da/pr_source.png/288x288bb.png)
![Flashlight Pro [Multipurpose LED light] screenshot](https://is1-ssl.mzstatic.com/image/thumb/Purple5/v4/22/cb/a7/22cba756-aaf1-d331-3b82-8b561a378712/pr_source.png/288x288bb.png)
![Flashlight Pro [Multipurpose LED light] screenshot](https://is1-ssl.mzstatic.com/image/thumb/Purple3/v4/1c/7a/46/1c7a4621-6d72-20d0-67bb-5153e1358f0e/pr_source.png/288x288bb.png)
Snapshot
Who is KAVAPOINT?
Providing specialized medical reference tools and utility applications for healthcare professionals and general users.
Target audience
Portfolio
Free 1Last updated
Flashlight Pro [Multipurpose LED light]
v3.0
12y ago
Publisher DNA
What defines KAVAPOINT?
Publisher DNA
Primary focus
Medical reference and utility applications
Scale
indie
Target audience
Healthcare professionals including physicians, nurses, and pharmacists, alongside general smartphone users seeking basic utility tools.
Signature Patterns
- •Focus on specialized medical reference content for clinical staff
- •Mixed monetization strategy utilizing both paid and free models
- •Long-term maintenance of legacy utility applications
- •Targeting professional niches alongside general-purpose mobile tools
Portfolio momentum
With only one release in the last six months and two out of three apps classified as abandoned, the publisher is currently in a maintenance or legacy phase.
Portfolio
What does KAVAPOINT ship?
Apps
3 apps analysed
- Offline-first architecture ensures reliability in remote clinical environments
Low-friction $0.99 price point lowers entry barrier
- Concise medical pearls provide high-value learning opportunities for busy clinical professionals during short breaks
- Lack of content updates leaves users reading stale information that does not reflect current evidence
Single-market publisher, every app ships only to United States.
Based on 1 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
65/100
Avg sentiment score
Rivals
Who does KAVAPOINT compete with?
The rivals identified
Nemeses(2)
Both apps target medication management, but they serve distinct use cases: Drugs & Medications provides clinical reference data for professionals, while My Next Med focuses on family-level adherence and dosing schedules.
Dominates the clinical reference space with high-frequency updates and a massive, established user base.
Contenders(2)
Leverages a massive professional network to integrate clinical reference tools with physician communication and career services.
Both apps target users managing medication, though they serve distinct clinical needs: Drugs & Medications provides reference data for professionals, while PillList focuses on patient adherence and scheduling.
Same space(17)
This app targets the educational needs of medical students, serving as a study aid rather than a clinical reference tool.
Sanford Guide provides specialized infectious disease data that serves as a high-frequency update alternative to the static Drugs & Medications database.
This app provides a similar clinical reference utility to Drugs & Medications but focuses specifically on the nursing professional segment.
Drugs.com provides a broader consumer-facing reference tool that complements the professional-only focus of Drugs & Medications.
This app provides a specialized pharmacology study tool that complements the reference data in Drugs & Medications.
This app provides a similar FDA-approved drug reference database to Drugs & Medications but adds cloud-based personalization features.
Epocrates serves the same professional medical audience as Drugs & Medications but offers a more complex clinical decision support suite.
This app offers a consumer-focused pill identification tool that overlaps with the pill identification features in Drugs & Medications.
GoodRx targets the same pharmacy-focused audience as Drugs & Medications but shifts the value from clinical reference to immediate financial savings via a 70,000+ pharmacy network.
PillEye automates the pharmacy inventory tasks that are manually referenced in Drugs & Medications.
Medisafe addresses the medication adherence gap left by the static reference model of Drugs & Medications.
This app provides a pill identification utility that complements the reference data found in Drugs & Medications.
MyRxProfile focuses on the safety-critical interaction checking that is a core component of medical reference apps like Drugs & Medications.
This app provides a concise pharmacology review that serves as a study companion to the clinical reference data in Drugs & Medications.
This app provides nursing-specific drug monographs similar to the professional content found in Drugs & Medications.
Davis's Drug Guide competes for the same nursing professional audience as Drugs & Medications but replaces static reference with active clinical tools like IV calculators.
Serves the same medical education and reference market but focuses on visual 3D anatomical modeling.
New entrants(2)
Shows high development velocity with ten releases in six months, signaling aggressive feature expansion.
Demonstrates strong growth in patient-facing symptom tracking with a high update frequency.
The Analyst's Read
The bottom line on KAVAPOINT
Bottom line
Kavapoint is a legacy publisher that successfully established a foothold in medical reference tools but currently lacks the development velocity to remain competitive in modern app stores. Their portfolio serves as a stable, niche reference library rather than an active growth engine.
Frequently asked questions
How many apps does KAVAPOINT publish?
What kind of apps does KAVAPOINT make?
What is KAVAPOINT's top app?
In how many countries are KAVAPOINT's apps available?
What fed this analysis
- Apps analyzed:
- 3
- With full intel:
- 0
- With overview:
- 3
- Website scraped:
- yes
- Social presence:
- no
